Understanding Non-small cell lung cancer patient Characteristics, treatment patterns and Outcomes - UNCOVER

Study identifier:D9260R00023

ClinicalTrials.gov identifier:NCT07215026

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Understanding Non-small cell lung cancer (NSCLC) patient Characteristics, treatment patterns and Outcomes Via cross-sEctional physicians suRvey-based chart audit

Medical condition

Non-small Cell Lung Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

800

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 27 Oct 2025
Estimated Primary Completion Date: 31 Dec 2025
Estimated Study Completion Date: 31 Dec 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria